Prognostic factors related to clinical outcome following thrombectomy in ischemic stroke (RECOST Study). 50 patients prospective study

被引:75
作者
Costalat, V. [1 ]
Lobotesis, K. [1 ]
Machi, P. [1 ]
Mourand, I. [1 ]
Maldonado, I. [1 ]
Heroum, C. [1 ]
Vendrell, J. F. [1 ]
Milhaud, D. [1 ]
Riquelme, C. [1 ]
Bonafe, A. [1 ]
Arquizan, C. [1 ]
机构
[1] CHU Montpellier, Montpellier, France
关键词
Ischemic stroke; Mechanical recanalization; Solitaire; Thrombectomy; TISSUE-PLASMINOGEN ACTIVATOR; BRAIN-BARRIER PERMEABILITY; PERFUSION-CT; MECHANICAL THROMBECTOMY; THROMBOLYTIC THERAPY; ARTERY OCCLUSIONS; RECANALIZATION; PREDICTS; RATES;
D O I
10.1016/j.ejrad.2012.07.012
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Background and aims: New thrombectomy devices allow successful and rapid recanalization in acute ischemic stroke. Nevertheless prognostics factors need to be systematically analyzed in the context of these new therapeutic strategies. The aim of this study was to analyze prognostic factors related to clinical outcome following Solitaire FR thrombectomy in ischemic stroke. Methods: Fifty consecutive ischemic stroke patients with large vessel occlusion were included. Three treatment strategies were applied; rescue therapy, combined therapy, and standalone thrombectomy. DWI ASPECT score <5 was the main exclusion criterion after initial MRI (T2, T2*, TOF, FLAIR, DWI). Sexes, age, time to recanalization were prospectively collected. Clinical outcome was assessed post treatment, day one and discharge by means of a NIHSS. Three months mRS evaluation was performed by an independent neurologist. The probability of good outcome at 3 months was assessed by forward stepwise logistic regression using baseline NIHSS score, Glasgow score at entrance, hyperglycemia, dyslipidemia, blood-brain barrier disruption on post-operative CT, embolic and hemorrhagic post procedural complication, ischemic brain lesion extension on 24 h imaging, NIHSS at discharge, ASPECT score, and time to recanalization. All variables significantly associated with the outcome in the univariate analysis were entered in the model. The significance of adding or removing a variable from the logistic model was determined by the maximum likelihood ratio test. Odds-ratio (OR) and their 95% confidence intervals were calculated. Results: At 3 months 54% of patients had a mRS 0-2, 70% in MCA, 44% in ICA, and 43% in BA with an overall mortality rate of 12%. Baseline NIHSS score (p = 0.001), abnormal Glasgow score at entrance (p = 0.053) hyperglycemia (p = 0.023), dyslipidemia (p = 0.031), blood-brain barrier disruption (p = 0.022), embolic and hemorrhagic post procedural complication, ischemic brain lesion extension on 24 h imaging (p = 0.008), NIHSS at discharge (0.001) were all factors significantly associated with 3 month clinical outcome. ASPECT subgroup (5-7 and 8-10), and time to recanalization were not correlated to 3 months outcome. Baseline NIHSS score (OR, 1.228; 95% CI, 1.075-1.402; p = 0.002), hyperglycemia (OR, 10.013; 95% CI, 1.068-93.915; p = 0.04), emerged as independent predictors of outcome at 3 months. Overall embolic complication rate was 10%, and symptomatic intracranial hemorrhage was 2%. Conclusion: The MCA location was associated with the best clinical outcome. A DWI ASPECT cutoff score of 5 was reliable and safe. No correlation with time to recanalization was observed in this study. NIHSS and hyperglycemia at admission were the two factors independently associated with a bad outcome at 90 days. (C) 2012 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:4075 / 4082
页数:8
相关论文
共 23 条
  • [1] Endovascular Treatment of Acute Ischemic Stroke May Be Safely Performed With No Time Window Limit in Appropriately Selected Patients
    Abou-Chebl, Alex
    [J]. STROKE, 2010, 41 (09) : 1996 - 2000
  • [2] Validity and reliability of a quantitative computed tomography score in predicting outcome of hyperacute stroke before thrombolytic therapy
    Barber, PA
    Demchuk, AM
    Zhang, JJ
    Buchan, AM
    [J]. LANCET, 2000, 355 (9216) : 1670 - 1674
  • [3] Increased Blood-Brain Barrier Permeability on Perfusion CT Might Predict Malignant Middle Cerebral Artery Infarction
    Bektas, Hesna
    Wu, Tzu-Ching
    Kasam, Mallikarjunarao
    Harun, Nusrat
    Sitton, Clark W.
    Grotta, James C.
    Savitz, Sean I.
    [J]. STROKE, 2010, 41 (11) : 2539 - 2544
  • [4] Stroke treatment with alteplase given 3.0-4.5 h after onset of acute ischaernic stroke (ECASS III): additional outcomes and subgroup analysis of a randomised controlled trial
    Bluhmki, Erich
    Chamorro, Angel
    Davalos, Antoni
    Machnig, Thomas
    Sauce, Christophe
    Wahlgren, Nils
    Wardlaw, Joanna
    Hacke, Werner
    [J]. LANCET NEUROLOGY, 2009, 8 (12) : 1095 - 1102
  • [5] The interventional management of stroke (IMS) II study
    Broderick, Joseph P.
    [J]. STROKE, 2007, 38 (07) : 2127 - 2135
  • [6] Mechanical Thrombectomy With the Solitaire AB Device in Large Artery Occlusions of the Anterior Circulation A Pilot Study
    Castano, Carlos
    Dorado, Laura
    Guerrero, Cristina
    Millan, Monica
    Gomis, Meritxell
    Perez de la Ossa, Natalia
    Castellanos, Mar
    Rosa Garcia, M.
    Domenech, Sira
    Davalos, Antoni
    [J]. STROKE, 2010, 41 (08) : 1836 - 1840
  • [7] Intravenous tissue plasminogen activator and flow improvement in acute ischemic stroke patients with internal carotid artery occlusion
    Christou, I
    Felberg, RA
    Demchuk, AM
    Burgin, WS
    Malkoff, M
    Grotta, JC
    Alexandrov, AV
    [J]. JOURNAL OF NEUROIMAGING, 2002, 12 (02) : 119 - 123
  • [8] Costalat VM, 2011, STROKE J CEREBRAL CI, P42
  • [9] Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II)
    Hacke, W
    Kaste, M
    Fieschi, C
    von Kummer, R
    Davalos, A
    Meier, D
    Larrue, V
    Bluhmki, E
    Davis, S
    Donnan, G
    Schneider, D
    Diez-Tejedor, E
    Trouillas, P
    [J]. LANCET, 1998, 352 (9136) : 1245 - 1251
  • [10] Hill MD, 2006, AM J NEURORADIOL, V27, P1612